Laramide Resources Stock Quote LAM - Stock Price, News, Charts, Message Board, Trades

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Premium

Current Price

0.61

Bid

0.625

Ask

0.775

Volume

0.00

0.00 Day's Range 0.00

0.475 52 Week Range 1.04

Market Cap

137.497M

Previous Close

0.61

Open

Last Trade

Last Trade Time

Financial Volume

VWAP

Average Volume (3m)

18,431

Shares Outstanding

225,404,696

Dividend Yield

PE Ratio

-29.81

Earnings Per Share (EPS)

-0.02

Revenue

Net Profit

-4.68M

Sector

Uranium-radium-vanadium Ores

Industry

Uranium-radium-vanadium Ores

Website

www.laramide.com

Headquarters

Toronto, Ontario, Can

Founded

1970

Laramide Resources Ltd is listed in the Uranium-radium-vanadium Ores sector of the Australian Stock Exchange with ticker LAM. The last closing price for Laramide Resources was AUD0.61. Over the last year, Laramide Resources shares have traded in a share price range of AUD 0.475 to AUD 1.04.

Laramide Resources currently has 225,404,696 shares outstanding. The market capitalization of Laramide Resources is AUD137.50 million. Laramide Resources has a price to earnings ratio (PE ratio) of -29.81.

FeaturedELEMENT79 GOLD CORP PROVIDES UPDATE ON CHACHAS COMMUNITY CHARTER AND REVENUE GENERATION, M&A ACTIVITIES

Form 8-K - Current report

LIXTE Biotechnology Holdings announces collaboration on a New Colon Cancer Clinical Trial

Clinical trial to test recent findings that show LIXTE’s lead clinical compound, LB-100, increases recognition of colon cancer cells by the immune system PASADENA, CA, June 14, 2024 (GLOBE...

LIXTE Biotechnology Holdings to Collaborate with Roche and Netherlands Cancer Institute in New Colon Cancer Clinical Trial

Clinical trial to test recent findings that show LIXTE’s lead clinical compound, LB-100, increases recognition of colon cancer cells by the immune system PASADENA, CA, June 14, 2024 (GLOBE...

Scientific Journal Reports Findings that Show LIXTE’s Lead Clinical Compound, LB-100, Increases Recognition of Colon Cancer Cells by the Immune System

LB-100 Generates Neo-Antigens in Cancer Cells that are Presented to the Immune System by Disrupting the Process of RNA Splicing PASADENA, CA, June 06, 2024 (GLOBE NEWSWIRE) -- LIXTE...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-0.005	-0.813008130081	0.615	0.615	0.61	16226	0.61	DE
4	-0.185	-23.2704402516	0.795	0.8	0.61	21968	0.77084625	DE
12	-0.19	-23.75	0.8	1.04	0.61	18431	0.84963918	DE
26	-0.25	-29.0697674419	0.86	1.04	0.61	10386	0.85335739	DE
52	0.1	19.6078431373	0.51	1.04	0.475	9956	0.79781515	DE
156	0.02	3.38983050847	0.59	1.16	0.425	7810	0.77477374	DE
260	0.31	103.333333333	0.3	1.16	0.25	7838	0.73524898	DE

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
AEVOAvenira Limited	AUD 0.004 (100.00%)	2M
NRZONeuRizer Ltd	AUD 0.002 (100.00%)	1M
HLXOHelix Resources Limited	AUD 0.002 (100.00%)	1.17M
BSAOBSA Ltd	AUD 0.10 (75.44%)	4.5k
VPRVolt Group Ltd	AUD 0.0015 (50.00%)	2.75M
CMOOCosmo Metals Ltd	AUD 0.01 (-50.00%)	106.89k
WHKOWhiteHawk Limited	AUD 0.001 (-50.00%)	445k
RIERiedel Resources Ltd	AUD 0.001 (-33.33%)	140k
MCTMetalicity Ltd	AUD 0.002 (-33.33%)	35.44M
EXTODExcite Technology Services Ltd	AUD 0.002 (-33.33%)	8.62M
MKLMighty Kingdom Limited	AUD 0.003 (-25.00%)	128.47M
ATHAlterity Therapeutics Ltd	AUD 0.004 (0.00%)	117.92M
PENPeninsula Energy Ltd	AUD 0.10 (-2.44%)	113.61M
LPDLepidico Ltd	AUD 0.0025 (25.00%)	62.09M
NWCNew World Resources Limited	AUD 0.019 (-20.83%)	60.76M